91 related articles for article (PubMed ID: 4236493)
1. [Substance P and salivary secretion].
Lembeck F; Starke K
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(5):375-85. PubMed ID: 4236493
[No Abstract] [Full Text] [Related]
2. [Effect of substance P-like peptides on salivary secretion].
Starke K; Lembeck F; Lorenz W; Weiss U; Geipert F
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):204-5. PubMed ID: 4239232
[No Abstract] [Full Text] [Related]
3. [Biliary and pancreatic secretion under the influence of substance P and a physalaemin derivative].
Starke K; Lembeck F; Lorenz W; Weiss U
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):269-74. PubMed ID: 4239253
[No Abstract] [Full Text] [Related]
4. [Sialogenic and smooth muscle stimulating activity of physalaemin derivatives and substance P].
Lembeck F; Oberdorf A; Starke K; Hettich R
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(4):338-45. PubMed ID: 4235434
[No Abstract] [Full Text] [Related]
5. [Sialogenic action of substance P and a physalaemin-like octapeptide upon infusion into various vessels].
Lembeck F; Starke K; Weiss U
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(4):329-37. PubMed ID: 4235433
[No Abstract] [Full Text] [Related]
6. Pharmacological activities of 2-(5-methyl-4-imidazolyl)ethylamine.
Bertaccini G; Impicciatore M; Vitali T; Plazzi V
Farmaco Sci; 1972 Aug; 27(8):680-2. PubMed ID: 5051352
[No Abstract] [Full Text] [Related]
7. Similar effects of substance P and related peptides on salivation and on phosphatidylinositol turnover in rat salivary glands.
Hanley MR; Lee CM; Michell RH; Jones LM
Mol Pharmacol; 1980 Jul; 18(1):78-83. PubMed ID: 6157980
[No Abstract] [Full Text] [Related]
8. [Pharmacology of eledoisin, physalaemin and their synthetic analogues-an example for the study of structure-effect relations of peptides].
Stopp G; Niedrich H
Z Arztl Fortbild (Jena); 1967 Mar; 61(6):315-22. PubMed ID: 5627501
[No Abstract] [Full Text] [Related]
9. [Chromatographic analysis of a substance P preparation from brain].
Zetler G; Baldauf J
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(1):86-98. PubMed ID: 4231713
[No Abstract] [Full Text] [Related]
10. [Isolation, determination and characterization of a new vasoactive polypeptide occurring in the vessel wall].
Laszt L
Angiologica; 1967; 4(3-4):147-60. PubMed ID: 4951613
[No Abstract] [Full Text] [Related]
11. [Pharmacology of a new potent analgesic].
Herrmann M; Steinbrecher W; Heldt W
Arzneimittelforschung; 1970 Aug; 20(8):977-83. PubMed ID: 5536518
[No Abstract] [Full Text] [Related]
12. [Peptide receptors for tachykinins in the human Fallopian tube].
Zetler G; Mönkemeier D; Wiechell H
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):97-111. PubMed ID: 4237045
[No Abstract] [Full Text] [Related]
13. The effects of cigarette exposure on rat salivary proteins and salivary glands.
Fujinami Y; Fukui T; Nakano K; Ara T; Fujigaki Y; Imamura Y; Hattori T; Yanagisawa S; Kawakami T; Wang PL
Oral Dis; 2009 Oct; 15(7):466-71. PubMed ID: 19500271
[TBL] [Abstract][Full Text] [Related]
14. Release of a substance P polypeptide from the cerebral cortex.
Shaw JE; Ramwell PW
Am J Physiol; 1968 Jul; 215(1):262-7. PubMed ID: 5690670
[No Abstract] [Full Text] [Related]
15. Action of carbamylcholine on the striated ducts glycogen in mammalian salivary glands.
Fava-De-Moraes F; Giuffrida R; Junqueira LC
Acta Histochem; 1967; 27(1):1-8. PubMed ID: 4968547
[No Abstract] [Full Text] [Related]
16. Studies on action of hypotensive substance from renal medulla on the heart and smooth muscle.
Swiderska-Kulikowa B
Bull Acad Pol Sci Biol; 1968; 16(12):787-90. PubMed ID: 5757767
[No Abstract] [Full Text] [Related]
17. Biologically homogenous substance P isolated from bovine hypothalami.
Strumillo-Dyba E; Wilmanska D; Traczyk W
Acta Physiol Pol; 1973; 24(5):685-6. PubMed ID: 4743791
[No Abstract] [Full Text] [Related]
18. [Specificity of substance P].
Lembeck F
Hoppe Seylers Z Physiol Chem; 1968 Jul; 349(7):931-2. PubMed ID: 5725833
[No Abstract] [Full Text] [Related]
19. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.
Naruganahalli KS; Sinha S; Hegde LG; Meru AV; Chugh A; Kumar N; Gupta JB; Ray A
Eur J Pharmacol; 2007 Oct; 572(2-3):207-12. PubMed ID: 17610864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
